Harmony Biosciences (NASDAQ:HRMY) just reported results for the first quarter of 2024.
- Harmony Biosciences reported earnings per share of 88 cents. This was above the analyst estimate for EPS of 62 cents.
- The company reported revenue of $154.62 million.
- This was 0.12% worse than the analyst estimate for revenue of $154.80 million.